CNS Pharmaceuticals, Inc. Share Price & Technical Analysis
CNSP · $5.42 (+7.33%)
Healthcare / Biotechnology
$5.42
+7.33%
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate can…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
135% return in May, 3% avg return in past 3 year May month.
55% return in 2026, -172% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | -45% | -23% | -15% | 135% | – | – | – | – | – | – | – | 55% |
| 25 | -21% | -49% | -42% | -14% | -5% | -22% | -18% | -22% | 45% | -12% | -8% | -25% | -193% |
| 24 | -81% | 10% | 25% | -45% | -1% | -82% | -79% | -51% | -15% | -17% | -7% | 8% | -337% |
| 23 | -8% | -19% | -46% | 61% | 16% | 21% | 2% | -24% | -34% | 85% | 0% | -39% | 14% |
| 22 | -21% | -37% | -13% | -1% | -11% | -3% | -16% | 7% | -27% | -20% | -44% | -23% | -207% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.50M
P/E ratio
—
52W high
$13.80
52W low
$1.90
Volume
22,996
Beta
0.54
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CNS Pharmaceuticals, Inc. share price today?
- CNS Pharmaceuticals, Inc. (CNSP) last traded around $5.42 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CNSP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CNSP. Download the app for real-time alerts.
- How can I analyze CNS Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.